Sunday, May 15, 2022
EU/3/21/2456: Orphan designation for the treatment of Friedreich's ataxia. Withdrawn
Sponsor: Novartis Gene Therapies EU Limited
The designation was withdrawn from the Union Register of orphan medicinal products in March 2022 upon request of the sponsor.
